J Clin Aesthet Dermatol. 2021;14(5):E61–E69. by Gillian Murray, MPharm, PG Dip Clin Pharm, INP; Cormac Convery, MB ChB, MSc, MASLMS; Lee Walker, BDS, MFDS, RCPSG, MJDF, RCS, ENG; and Emma Davies, RN INP Dr. Murray is with Clinical Academic Kings College in London, England. Dr. Convery is with The Ever Clinic in Glasgow, Scotland. Dr. Walker
J Clin Aesthet Dermatol. 2020;13(9):33–40 by Benjeev Dhillon, MD, and Tapan Patel, MBBS Dr. Dhillon is with Define Clinic in Beaconsfield, United Kingdom. Dr. Patel is with PHI Clinic in London, United Kingdom. FUNDING: This study was funded by Allergan. DISCLOSURES: Dr. Dhillon is a former employee of Allergan, an Allergan stockholder, and a consultant
Vascular occlusion has been cited as the most severe and feared early complication in aesthetic treatment1 and the incidence appears to be on the increase.
Click to view the e-Edition of this supplement A Roundtable Discussion with W. Philip Werschler, MD, FAAD, FAACS; Edward M. Zimmerman, MD; Anita Mandal, MD; E. Victor Ross, MD; Craig F. Teller, MD; and Gregory Laurence, MD Dr. Werschler is Assistant Clinical Professor of Dermatology at the University of Washington School of Medicine in Seattle, Washington.
Michael H. Gold, MD Dr. Gold is the founder and medical director of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser and Rejuvenation Center, and Tennessee Clinical Research Center located in Nashville, Tennessee. He is also Clinical Assistant Professor at Vanderbilt University School of Medicine and School of Nursing in Nashville, Tennessee;